358 related articles for article (PubMed ID: 31865282)
1. "Randomised controlled trial of scalp cooling for the prevention of chemotherapy induced alopecia".
Bajpai J; Kagwade S; Chandrasekharan A; Dandekar S; Kanan S; Kembhavi Y; Ghosh J; Banavali SD; Gupta S
Breast; 2020 Feb; 49():187-193. PubMed ID: 31865282
[TBL] [Abstract][Full Text] [Related]
2. Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial.
Nangia J; Wang T; Osborne C; Niravath P; Otte K; Papish S; Holmes F; Abraham J; Lacouture M; Courtright J; Paxman R; Rude M; Hilsenbeck S; Osborne CK; Rimawi M
JAMA; 2017 Feb; 317(6):596-605. PubMed ID: 28196254
[TBL] [Abstract][Full Text] [Related]
3. Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.
Rugo HS; Klein P; Melin SA; Hurvitz SA; Melisko ME; Moore A; Park G; Mitchel J; Bågeman E; D'Agostino RB; Ver Hoeve ES; Esserman L; Cigler T
JAMA; 2017 Feb; 317(6):606-614. PubMed ID: 28196257
[TBL] [Abstract][Full Text] [Related]
4. Scalp cooling successfully prevents alopecia in breast cancer patients undergoing anthracycline/taxane-based chemotherapy.
Vasconcelos I; Wiesske A; Schoenegg W
Breast; 2018 Aug; 40():1-3. PubMed ID: 29660543
[TBL] [Abstract][Full Text] [Related]
5. The effect of scalp cooling on CIA-related quality of life in breast cancer patients: a systematic review.
Marks DH; Okhovat JP; Hagigeorges D; Manatis-Lornell AJ; Isakoff SJ; Lacouture ME; Senna MM
Breast Cancer Res Treat; 2019 Jun; 175(2):267-276. PubMed ID: 30806923
[TBL] [Abstract][Full Text] [Related]
6. COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer.
Smetanay K; Junio P; Feißt M; Seitz J; Hassel JC; Mayer L; Matthies LM; Schumann A; Hennigs A; Heil J; Sohn C; Jaeger D; Schneeweiss A; Marmé F
Breast Cancer Res Treat; 2019 Jan; 173(1):135-143. PubMed ID: 30255454
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy.
Cigler T; Isseroff D; Fiederlein B; Schneider S; Chuang E; Vahdat L; Moore A
Clin Breast Cancer; 2015 Oct; 15(5):332-4. PubMed ID: 25749072
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of scalp cooling system in preventing chemotherapy induced alopecia - A single center prospective study.
Kate S; Patil R; Pathan D; Vyavhare R; Joseph S; Baby V; Ramesh YV; Nagarkar R
Cancer Treat Res Commun; 2021; 26():100280. PubMed ID: 33338853
[TBL] [Abstract][Full Text] [Related]
9. Prospective Study Investigating the Efficacy and Safety of a Scalp Cooling Device for the Prevention of Alopecia in Women Undergoing (Neo)Adjuvant Chemotherapy for Breast Cancer.
Carbognin L; Accetta C; Di Giorgio D; Fuso P; Muratore M; Tiberi G; Pavese F; D'Angelo T; Fabi A; Giannarelli D; Di Leone A; Magno S; Garganese G; Sanchez AM; Terribile DA; Franceschini G; Masetti R; Scambia G; Paris I
Curr Oncol; 2022 Sep; 29(10):7218-7228. PubMed ID: 36290846
[TBL] [Abstract][Full Text] [Related]
10. Hair Loss Prevention by a Scalp Cooling Device in Early Breast Cancer Patients: The Poliambulanza Preliminary Experience.
Prochilo T; Huscher A; Andreis F; Mirandola M; Zaina E; Pomentale B; Pedrali C; Zanotti L; Mutti S; Zaniboni A
Rev Recent Clin Trials; 2019; 14(1):66-71. PubMed ID: 30457055
[TBL] [Abstract][Full Text] [Related]
11. Prospective observational study of chemotherapy-induced alopecia after sequential FEC + taxane and the effects of age in breast cancer patients.
Fujii T; Ichiba K; Honda C; Tokuda S; Nakazawa Y; Ogino M; Kurozumi S; Obayashi S; Yajima R; Shirabe K
Breast Cancer; 2021 Mar; 28(2):329-334. PubMed ID: 32944881
[TBL] [Abstract][Full Text] [Related]
12. Does Scalp Cooling Have the Same Efficacy in Black Patients Receiving Chemotherapy for Breast Cancer?
Dilawari A; Gallagher C; Alintah P; Chitalia A; Tiwari S; Paxman R; Adams-Campbell L; Dash C
Oncologist; 2021 Apr; 26(4):292-e548. PubMed ID: 33512741
[TBL] [Abstract][Full Text] [Related]
13. Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with anthracyclines.
Munzone E; Bagnardi V; Campennì G; Mazzocco K; Pagan E; Tramacere A; Masiero M; Iorfida M; Mazza M; Montagna E; Cancello G; Bianco N; Palazzo A; Cardillo A; Dellapasqua S; Sangalli C; Pettini G; Pravettoni G; Colleoni M; Veronesi P
Br J Cancer; 2019 Aug; 121(4):325-331. PubMed ID: 31303642
[TBL] [Abstract][Full Text] [Related]
14. Prolonging the duration of post-infusion scalp cooling in the prevention of anthracycline-induced alopecia: a randomised trial in patients with breast cancer treated with adjuvant chemotherapy.
Komen MMC; van den Hurk CJG; Nortier JWR; van der Ploeg T; Nieboer P; van der Hoeven JJM; Smorenburg CH
Support Care Cancer; 2019 May; 27(5):1919-1925. PubMed ID: 30206728
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of scalp cooling in reducing alopecia in early breast cancer patients receiving contemporary chemotherapy regimens.
Chan A; Bauwens A; Pontre S; Jackson S; McGlone F; Ernenwein T; Chih J; Reid C
Breast; 2018 Oct; 41():127-132. PubMed ID: 30048865
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Prevention Interventions for Taxane-Induced Dermatologic Adverse Events: A Systematic Review.
Marks DH; Qureshi A; Friedman A
JAMA Dermatol; 2018 Dec; 154(12):1465-1472. PubMed ID: 30383138
[TBL] [Abstract][Full Text] [Related]
17. Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective study.
Giarratano T; Frezzini S; Zanocco M; Giorgi CA; Mioranza E; Miglietta F; Griguolo G; Falci C; Faggioni G; Tasca G; Di Liso E; Vernaci G; Menichetti A; Mantiero M; Grosso D; Guarneri V; Dieci MV
Breast J; 2020 Jul; 26(7):1296-1301. PubMed ID: 31837103
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of increasing the scalp cooling duration to prevent alopecia during adjuvant chemotherapy for breast cancer: a randomized pilot study.
Carton E; Blas AM; Perret C; Le Bihan M
Support Care Cancer; 2024 Jun; 32(7):410. PubMed ID: 38839667
[TBL] [Abstract][Full Text] [Related]
19. Impact of chemotherapy regimen and sequence on the effectiveness of scalp cooling for alopecia prevention.
Villarreal-Garza C; Mesa-Chavez F; Garza-Ledezma MRA; Peña-Curiel O; Martinez-Cannon BA; Canavati-Marcos M; Cardona-Huerta S
Breast Cancer Res Treat; 2021 Jan; 185(2):453-458. PubMed ID: 33125621
[TBL] [Abstract][Full Text] [Related]
20. Scalp Cooling for Prevention of Chemotherapy-Induced Alopecia for Women and Men with Various Cancer Entities: A Two-Year Survey of an Outpatient Cancer Center in Germany.
Keim S; Hempel L; Ebner F; Retzer-Lidl M; Wohlmuth K; Hempel D; Milani V
Oncol Res Treat; 2022; 45(7-8):395-399. PubMed ID: 35220298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]